About Us

through a variety of programs: AMR specific CME courses for clinicians, making educational materials available to patients in clinical settings and via social media, sponsoring community-oriented educational fundraising events, and working with a wide range of government agencies to take immediate action in the promotion of antibiotic stewardship.

for infections by collaborating with other foundations and communities worldwide and offering assistance with the utilization of NGS diagnostic for accurate diagnosis and providing accurate treatment options.

for healthcare facilities that will combat pathogens colonizing on surfaces and in medical equipment, helping to eliminate the chance of further infections.

by using multiple phage therapy DNA libraries in conjunction with a NGS curated database in order to identify and match specific phages with specific bacteria, eliminating the need for ambiguous phage cocktails. Also, introduce this protocol to the FDA and healthcare system to provide an alternate solution to antibiotics due to the increase of AMR. (Focusing first on the WHO Bacterial Priority Pathogens list, 2024.)

necessary for FDA approval to further advance open usage of phage therapy and implementation in our healthcare system.

Bacteria Without Borders is dedicated to raising global awareness of antimicrobial resistance (AMR) with an emphasis on bacterial antibiotic resistance. Our mission is to educate the public and healthcare professionals about AMR, its causes, and strategies for reduction and elimination.

We will achieve this through a variety of initiatives: 

Our vision is to save the world one infection at a time, promoting antibiotic stewardship and responsible treatment practices among all people. We aim to stop antibiotic resistance from becoming the #1 cause of death worldwide by implementing innovative molecular diagnostics and advancing alternative therapies and treatments.

Our mission serves all people, focusing on those affected by infections, partnering with medical and technological experts, and engaging investors to support our cause. Together, we strive to create a world where AMR is significantly reduced by making accurate treatments accessible to all.

Our Board of Directors

Tara Hicks

Founder/President

Aaron Hicks

Vice President/Secretary

Sharon McDonough

Treasurer

Emmanuelle Houjib, PA-C

Board Member

Nicholas Sanford, Ph.D, BCMAS

Biotech and Molecular Expert, Board Member

Dr. James Ian McMillen, MD, FIDSA

Infectious Disease Specialist, Board Member

Join Our Newsletter

Please enable JavaScript in your browser to complete this form.
Name